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Abstract. The development of  sarcomas in smal lpox 
vaccination scars is very rare. Including this case, only 
five have been reported. This is the first report of  a 
le iomyosarcoma arising in a smal lpox vaccination scar. 
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In 1882, Mar jo l in  descr ibed a squamous cell carc inoma 
developing in a chronic leg ulcer [1]. "Mar jo l in 's  ulcer" 
describes mal ignancy in scars [2], venous stasis ulcers, 
chronic osteomyel i t is  and chronic f istula and sinuses [3], 
i rradiat ion dermatit is [4], chronic traumatic wounds [5], 
and pressure sores [6]. 
Cancers arising in scars of  smal lpox vaccinations are 
uncommon,  the first being reported by Auger  in 1943 
[7]. These are usual ly of  epithel ial  origin. 
In 1993, a patient presented with a le iomyosarcoma 
in a recurrent hypertrophic smal lpox vaccination scar; it 
inf i ltrated the underly ing subcutis and musculature [8]. 
This is the first report of  a le iomyosarcoma arising in a 
smal lpox vaccinat ion scar. 
Case report 
A 33-year-old female was vaccinated against smallpox on her left 
deltoid area. Five years later in 1976, a painful nodule 1.5 cm in 
diameter developed in the scar. The clinical diagnosis was a hy- 
pertrophic scar. It was excised but six years later it recurred and 
was again excised (1982). A second recurrence was excised in 
1987. Histology confirmed the clinical diagnosis of scar hyper- 
trophy. 
Four months after this a painful nodule appeared. Six years la- 
ter 1993, because of patient delay, a biopsy revealed a leiomyosar- 
coma. MRI and CT scans (Figs. 5, 6) determined the extent of the 
tumor and the patient was referred to us. 
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There was a 6 cm in diameter painful mass (Fig. 1) with a 1 
cm nodule in the oblique scar of her left shoulder. The tumor was 
widely excised with the superficial portion of the underlying del- 
toid, the defect being 10.5 cm in diameter (Fig. 2). A split thick- 
ness skin graft was applied. 
A biopsy of a scar-like structure in the skin transplant revealed 
another recurrence in October 1995. Resection of the deltoid 
muscle and musculocutaneous reconstruction, supplemented by 
pre- and postoperative radiotherapy was proposed but rejected by 
the patient. 
Investigations 
• Preoparative CT scans showed a lobular mass on the left deltoid 
area measuring 5 cm in the anteroposterior and 4 cm in the latero- 
lateral scan (Fig. 5). It was located in the subcutaneous ti sue, in- 
filtrating the cutis with elevation of the overlying scar and adja- 
cent skin. No local and regional adenopathy was present. 
• Preoperative MRI confirmed the CT scan findings (Fig. 6). The 
superficial muscle fibers of the deltoid were infiltrated. 
• Histology showed proliferated spindle-shaped cells with abun- 
dant eosinophilic, fibrillar cytoplasm. Polymorphism was rare. 
Mitotic rate was 15-20 per 10 HPF (x400) (Fig. 7). The leiomyo- 
sarcoma was mainly located in the subcutis. It infiltrated the der- 
mis superficially and deeply spot-like in the deltoid muscle (Fig. 
8). Histology of the overlying dermis showed characteristics of 
scar hypertrophy (preceding excisions and biopsies). Diagnosis - 
grade II sarcoma. 
• Immunohistochemistry confirmed the presence of muscle specif- 
ic actin and desmin, but absence of cytokeratin and vimentin. 
Discussion 
Mal ignant tumors arising in smal lpox vaccination scars 
are rare. The first was reported in 1943 [7], and 70 cases, 
including our one, have been descr ibed [8]. Of  these, 48 
were male and 22 female, 58% after pr imary vaccina- 
tion, 25% after revaccination, and 17% unknown. The 
mean age of  patients was 53 years, the youngest patient 
being 15, the oldest 81. The mean latent per iod (interval 
between vaccination and onset of  the lesion or consult- 
ing a physician) was 25 year. Three patients were Black, 
the major i ty were Causacians. Risk factors were long- 
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Fig. 1. Preoperative condition shows the leiomyosarcoma in a re- 
current hypertrophic smallpox vaccination scar. A nodule is visi- 
ble at one end of a 3 cm long scar 
Fig. 2. Intraoperative iew after wide local excision of the tumour. 
The cutis, subcutis and superficial part of the deltoid muscle have 
been removed 
Fig. 3. The undersurface of the excised specimen containing the 
tumoral mass is shown in this figure 
Fig. 4. Postoperative condition after 4 months. The wound had 
been covered with thin split thickness kin graft. The tissue defect 
has still not been reconstructed for oncologic reasons 
Fig. 5. CT-scan at the level of the upper chest shows the tumour 
infiltrating the subcutaneous fat and the superficial part of the del- 
toid muscle. The tumoral mass presents the same density as the 
adjacent muscles 
Fig. 6. This MRI shows the location of the turnout in the subcuta- 
neous fat overlying the deltoid muscle 
Fig. 7. Mitoses of the superficial leiomyosarcoma are shown in 
this figure. The tumour consists of fascicles intersecting atvarious 
angles (HE, x30) 
Fig. 8. This figure shows the leiomyosarcoma invading the dermis 
(HE, xl0) 
Fig. 9. This figure shows the leiomyosarcoma infiltrating the sub- 
cutaneous fat (HE, xl0) 
term physical  irritation such as sun exposure or chronic 
scarring, the treatment of  choice was local excision 
[8]. 
F i f ty-seven percent of mal ignancies in smal lpox vac- 
cination scars were basal  cell carcinomas. The male to 
female ratio was 3:1. The mean age of  patients was 54 
years. The mean latent per iod was 24 years [8]. 
Twenty-two percent of all reported mal ignancies in 
smal lpox vaccination scars were mal ignant melanomas.  
The male to female ratio was 3:2. The mean age of  pa- 
tients was 49 years, 50% arising between 39 and 58 
years. The mean latent per iod was 22 years [8]. 
Fourteen percent of  all reported mal ignancies in 
smal lpox vaccination scars were squamous cell carcino- 
100 
mas. The male to female ratio was 2; 1. The mean age of 
patients was 55 years. The mean latent period was 19 
years [81. 
Seven percent of all reported malignancies in small- 
pox vaccination scars were sarcomas. This represented 
five cases, one fibrosarcoma, two dermatofibrosarcomas 
protuberans, one malignant fibrohistiocytoma, and this 
leiomyosarcoma. 
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